Suppr超能文献

基于槲皮素负载月桂酸单糖酯的非离子表面活性剂囊泡:缓释及抗氧化-肝保护相互作用

Quercetin Loaded Monolaurate Sugar Esters-Based Niosomes: Sustained Release and Mutual Antioxidant-Hepatoprotective Interplay.

作者信息

Elmowafy Enas, El-Derany Marwa O, Biondo Francesca, Tiboni Mattia, Casettari Luca, Soliman Mahmoud E

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Monazzamet Elwehda Elafrikeya Street, P.O.B. 11566, Abbaseyya, Cairo, Egypt.

Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Monazzamet Elwehda Elafrikeya Street, P.O.B. 11566, Abbaseyya, Cairo, Egypt.

出版信息

Pharmaceutics. 2020 Feb 9;12(2):143. doi: 10.3390/pharmaceutics12020143.

Abstract

Flavonoids possess different interesting biological properties, including antibacterial, antiviral, anti-inflammatory and antioxidant activities. However, unfortunately, these molecules present different bottlenecks, such as low aqueous solubility, photo and oxidative degradability, high first-pass effect, poor intestinal absorption and, hence, low systemic bioavailability. A variety of delivery systems have been developed to circumvent these drawbacks, and among them, in this work niosomes have been selected to encapsulate the hepatoprotective natural flavonoid quercetin. The aim of this study was to prepare nanosized quercetin-loaded niosomes, formulated with different monolaurate sugar esters (i.e., sorbitan C12; glucose C12; trehalose C12; sucrose C12) that act as non-ionic surfactants and with cholesterol as stabilizer (1:1 and 2:1 ratio). Niosomes were characterized under the physicochemical, thermal and morphological points of view. Moreover, after the analyses of the in vitro biocompatibility and the drug-release profile, the hepatoprotective activity of the selected niosomes was evaluated in vivo, using the carbon tetrachloride (CCl)-induced hepatotoxicity in rats. Furthermore, the levels of glutathione and glutathione peroxidase (GSH and GPX) were measured. Based on results, the best formulation selected was glucose laurate/cholesterol at molar ratio of 1:1, presenting spherical shape and a particle size (PS) of 161 ± 4.6 nm, with a drug encapsulation efficiency (EE%) as high as 83.6 ± 3.7% and sustained quercetin release. These niosomes showed higher hepatoprotective effect compared to free quercetin in vivo, measuring serum biomarker enzymes (i.e., alanine and aspartate transaminases (ALT and AST)) and serum biochemical parameters (i.e., alkaline phosphatase (ALP) and total proteins), while following the histopathological investigation. This study confirms the ability of quercetin loaded niosomes to reverse CCl intoxication and to carry out an antioxidant effect.

摘要

黄酮类化合物具有多种有趣的生物学特性,包括抗菌、抗病毒、抗炎和抗氧化活性。然而,不幸的是,这些分子存在不同的瓶颈,如低水溶性、光降解性和氧化降解性、高首过效应、肠道吸收差,因此全身生物利用度低。人们已经开发了多种递送系统来克服这些缺点,其中,在这项工作中选择了非离子型表面活性剂囊泡来包裹具有肝脏保护作用的天然黄酮类化合物槲皮素。本研究的目的是制备纳米尺寸的载槲皮素非离子型表面活性剂囊泡,用不同的单月桂酸糖酯(即脱水山梨醇C12;葡萄糖C12;海藻糖C12;蔗糖C12)作为非离子表面活性剂,并以胆固醇作为稳定剂(1:1和2:1比例)进行配制。从物理化学、热学和形态学角度对非离子型表面活性剂囊泡进行了表征。此外,在分析体外生物相容性和药物释放曲线后,使用四氯化碳(CCl)诱导的大鼠肝毒性在体内评估了所选非离子型表面活性剂囊泡的肝脏保护活性。此外,还测量了谷胱甘肽和谷胱甘肽过氧化物酶(GSH和GPX)的水平。根据结果,选择的最佳配方是月桂酸葡萄糖/胆固醇摩尔比为1:1,呈球形,粒径(PS)为161±4.6nm,药物包封率(EE%)高达83.6±3.7%,槲皮素持续释放。在组织病理学研究中,与游离槲皮素相比,这些非离子型表面活性剂囊泡在体内表现出更高的肝脏保护作用,检测了血清生物标志物酶(即丙氨酸和天冬氨酸转氨酶(ALT和AST))和血清生化参数(即碱性磷酸酶(ALP)和总蛋白)。本研究证实了载槲皮素非离子型表面活性剂囊泡具有逆转CCl中毒和发挥抗氧化作用的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b4/7076437/1d4c33cd8795/pharmaceutics-12-00143-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验